Category Archives: Business of Biotech

SBIR Funds Speed the Delivery of Breakthrough Treatments and Cures

scientists115x76

Today, BIO’s Executive Vice President of Emerging Companies Cartier Esham presented testimony to the U.S. House of Representatives Committee on Small Business regarding oversight of the Small Business Innovation Research and Small Business Technology Transfer Programs (SBIR/STTR). Dr. Esham emphasized that SBIR plays a critical role in supporting small biotech companies and funding their early-stage research as they navigate the “valley of death,” a critical time when the scientific concepts have shown promise but the Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

A Better Way To Ship Temperature-Sensitive Materials

Dewar copy

With the business needs of the life science industry in mind, FedEx® has expanded its shipping service portfolio to include Deep Frozen Shipping Solution. Participants of BIO Business Solutions® can now access a discounted, non-hazardous, liquid nitrogen dry vapor technology with end-to-end shipment monitoring. This safe and cost-effective option for the shipment of expensive, temperature-sensitive biogenetics and biomaterials, has a 10-day holding time (below -150oC) that allows samples and substances to be mailed globally without having to worry about sublimation or Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Participate in the 11th Annual Biopharmaceutical Manufacturing Report and Survey

Participate in the biopharmaceutical manufacturing industry’s most in-depth, global study: 11th Annual Biopharmaceutical Manufacturing Report and Survey. Your input is more important than ever, as BioPlan Associates benchmarks global and regional trends affecting the industry. You will receive a free summary of the results of the study as well as BioPlan’s 159 Key Industry Facts White Paper. For each completed survey BioPlan will donate $10 (up to $10,000) to global health charities. The survey takes Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,

BIO Testifies Before The Michigan Bioscience Caucus

admin-ajax

BIO‘s Senior Policy Consultant, Peter Pellerito, recently testified before the Michigan Legislature’s Bioscience Caucus on economic development initiatives that support the growth of the bioscience industry. As part of the testimony, Pellerito discussed state legislative capital formation and R&D legislative strategies that support technology transfer and industry growth within state borders. Read the transcript of the testimony here.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

The New Road to IPO in the Age of the JOBS Act

President Obama

Not surprisingly, sessions discussing the topic of IPOs at this year’s BIO Investor Forum, tend to fill the room. Furthermore, it should surprise no one that this year’s IPO discussions were upbeat. That is mostly attributable to the dramatically higher number of IPOs that have already occurred this year. Furthermore, according to Jeff Baumel, moderator of a panel covering this very topic, deals are closing faster this year – with a median time of just Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,